Oncternal Therapeutics, Inc. reports

Company location: San Diego, CA
Fiscal year end: 31 December

Oncternal Therapeutics, Inc. has filed 1,606 SEC EDGAR filings since 21 Aug 2003

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 726-750 of 1,000 matching filings.

Per page

25

Current page

30

8-K File 000-50549

8-K

Filing date: 06 Mar 2014
Reporting date: 06 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50549

8-K

Filing date: 04 Mar 2014
Reporting date: 03 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50549

8-K

Filing date: 04 Mar 2014
Reporting date: 04 Mar 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-79588

SC 13G/A

Filing date: 14 Feb 2014
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50549

8-K

Filing date: 10 Feb 2014
Reporting date: 10 Feb 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 31 Jan 2014
Reporting date: 29 Jan 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 31 Jan 2014
Reporting date: 21 Jan 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50549

8-K

Filing date: 29 Jan 2014
Reporting date: 29 Jan 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 06 Jan 2014
Reporting date: 02 Jan 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 06 Jan 2014
Reporting date: 02 Jan 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 06 Jan 2014
Reporting date: 02 Jan 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

3/A

3/A

Filing date: 30 Dec 2013
Reporting date: 20 Dec 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 -

Filing date: 30 Dec 2013
Reporting date: 20 Dec 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50549

8-K

Filing date: 23 Dec 2013
Reporting date: 20 Dec 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-50549

10-Q

Filing date: 12 Nov 2013
Reporting date: 30 Sep 2013
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-50549

8-K

Filing date: 12 Nov 2013
Reporting date: 12 Nov 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50549

8-K

Filing date: 24 Oct 2013
Reporting date: 24 Oct 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 02 Oct 2013
Reporting date: 01 Oct 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 02 Oct 2013
Reporting date: 01 Oct 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 02 Oct 2013
Reporting date: 01 Oct 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 02 Oct 2013
Reporting date: 01 Oct 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 02 Oct 2013
Reporting date: 01 Oct 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-50549

8-K

Filing date: 01 Oct 2013
Reporting date: 27 Sep 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A File 005-79588

SCHEDULE 13D/A

Filing date: 09 Sep 2013
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A File 005-79588

SCHEDULE 13D AMENDMENT NO. 4

Filing date: 26 Aug 2013
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .